Life ScienceCompany
CTI BioPharma M&A Summary
CTI BioPharma has acquired 1 company of its own. It has also divested 1 asset.
CTI BioPharma has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
CTI BioPharma Ownership
Who owns CTI BioPharma?
CTI BioPharma is owned by Swedish Orphan Biovitrum AB. It was acquired on May 10, 2023.
CTI BioPharma Business Overview
Where is CTI BioPharma headquartered?
CTI BioPharma is headquartered in Seattle, Washington.
What is CTI BioPharma’s revenue?
CTI BioPharma disclosed revenue of 54M USD for 2022 and 3M USD for 2019.
How many employees does CTI BioPharma have?
CTI BioPharma has 144 employees.
What sector is CTI BioPharma in?
CTI BioPharma is a life science company.
When was CTI BioPharma founded?
CTI BioPharma was founded in 1991.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1